FilingReader Intelligence
Piramal Pharma receives "61" ESG rating from NSE Sustainability
July 10, 2025 at 05:59 AM UTC•By FilingReader AI
Piramal Pharma announced that NSE Sustainability Ratings and Analytics has assigned the company an Environment, Social, and Governance (ESG) Rating of "61" for the fiscal year 2023-24. This rating is based on data publicly available.
This report was generated by FilingReader's AI system from regulatory filings and company disclosures. To request a correction, contact editorial@filingreader.com
BSE:PPLPHARMA•Bombay Stock Exchange
News Alerts
Get instant email alerts when PIRAMAL PHARMA publishes news
Free account required • Unsubscribe anytime